<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>HERMS Insights: Blogs and White Papers</title>
<link>https://www.hermsglobal.com/blog</link>
<atom:link href="https://www.hermsglobal.com/rss.xml" rel="self" type="application/rss+xml"/>
<description>Regulatory, market access and healthcare intelligence articles and white papers from HERMS Consultancy DMCC.</description>
<language>en</language>
<ttl>360</ttl>
<lastBuildDate>Mon, 16 Nov 2026 14:18:23 +0000</lastBuildDate>
<item>
<title>Cell and Gene Therapies Worldwide: The Developments Reshaping 2026</title>
<link>https://www.hermsglobal.com/cell-gene-therapies-worldwide-latest-updates-2026</link>
<guid isPermaLink="true">https://www.hermsglobal.com/cell-gene-therapies-worldwide-latest-updates-2026</guid>
<pubDate>Mon, 16 Nov 2026 14:18:23 +0000</pubDate>
<category>ADVANCED THERAPIES</category>
<description>A November 2026 review of cell and gene therapy approvals, global regulatory developments and manufacturing readiness, with primary-source links.</description>
</item>
<item>
<title>The Latest Robotics Innovations in Healthcare and Life Sciences</title>
<link>https://www.hermsglobal.com/latest-robotics-innovations-healthcare-life-sciences-2026</link>
<guid isPermaLink="true">https://www.hermsglobal.com/latest-robotics-innovations-healthcare-life-sciences-2026</guid>
<pubDate>Mon, 16 Nov 2026 14:17:23 +0000</pubDate>
<category>ROBOTICS</category>
<description>Explore 2026 advances in surgical force feedback, robotic instrumentation and AI-connected laboratories, separating deployment from research.</description>
</item>
<item>
<title>Stem Cell Treatments: The Latest Innovations and Their Evidence Status</title>
<link>https://www.hermsglobal.com/latest-stem-cell-treatment-innovations-2026</link>
<guid isPermaLink="true">https://www.hermsglobal.com/latest-stem-cell-treatment-innovations-2026</guid>
<pubDate>Mon, 16 Nov 2026 14:16:23 +0000</pubDate>
<category>STEM CELLS</category>
<description>Review Japan&apos;s iPSC milestones, transplant engineering and investigational islet-cell replacement while separating approvals from experimental treatments.</description>
</item>
<item>
<title>Diagnostic Devices and Platforms: The Latest Innovations Changing Clinical Decisions</title>
<link>https://www.hermsglobal.com/latest-diagnostic-devices-platforms-innovations-2026</link>
<guid isPermaLink="true">https://www.hermsglobal.com/latest-diagnostic-devices-platforms-innovations-2026</guid>
<pubDate>Mon, 16 Nov 2026 14:15:23 +0000</pubDate>
<category>DIAGNOSTICS</category>
<description>A source-linked review of molecular residual disease testing, Alzheimer&apos;s blood biomarkers and photon-counting CT, focused on clinical use and implementation.</description>
</item>
<item>
<title>AI in Life Sciences: The Latest Innovations Moving from Prediction to Experiment</title>
<link>https://www.hermsglobal.com/latest-ai-innovations-life-sciences-2026</link>
<guid isPermaLink="true">https://www.hermsglobal.com/latest-ai-innovations-life-sciences-2026</guid>
<pubDate>Mon, 16 Nov 2026 14:14:23 +0000</pubDate>
<category>AI IN LIFE SCIENCES</category>
<description>Explore AlphaGenome Atlas, programmable protein design and AI-connected wet labs, with a practical framework for evidence, validation and accountable adoption.</description>
</item>
<item>
<title>Why Healthcare Execution Fails Between Functions</title>
<link>https://www.hermsglobal.com/why-healthcare-execution-fails-between-functions</link>
<guid isPermaLink="true">https://www.hermsglobal.com/why-healthcare-execution-fails-between-functions</guid>
<pubDate>Mon, 16 Nov 2026 14:13:23 +0000</pubDate>
<category>PLATFORM</category>
<description>The gaps that delay patient access sit between departments, not inside them.</description>
</item>
<item>
<title>From Consulting to Intelligence: The HERMS Platform Model</title>
<link>https://www.hermsglobal.com/from-consulting-to-intelligence-the-herms-platform-model</link>
<guid isPermaLink="true">https://www.hermsglobal.com/from-consulting-to-intelligence-the-herms-platform-model</guid>
<pubDate>Mon, 16 Nov 2026 14:12:23 +0000</pubDate>
<category>PLATFORM</category>
<description>Thirteen years of consulting became the foundation for a software platform.</description>
</item>
<item>
<title>The Intelligence Spine: Built Once, Inherited by Every Application</title>
<link>https://www.hermsglobal.com/the-intelligence-spine-built-once-inherited-by-every-application</link>
<guid isPermaLink="true">https://www.hermsglobal.com/the-intelligence-spine-built-once-inherited-by-every-application</guid>
<pubDate>Mon, 16 Nov 2026 14:11:23 +0000</pubDate>
<category>INTELLIGENCE</category>
<description>Why a shared foundation is the real advantage in healthcare software: one intelligence spine, built once and inherited by every HERMS application.</description>
</item>
<item>
<title>The Unwritten Rules of Regional Execution, Codified</title>
<link>https://www.hermsglobal.com/the-unwritten-rules-of-regional-execution-codified</link>
<guid isPermaLink="true">https://www.hermsglobal.com/the-unwritten-rules-of-regional-execution-codified</guid>
<pubDate>Mon, 16 Nov 2026 14:10:23 +0000</pubDate>
<category>INTELLIGENCE</category>
<description>In healthcare and life sciences, the rules that decide success are rarely written down.</description>
</item>
<item>
<title>The Model Proposes, the Rules Engine Decides</title>
<link>https://www.hermsglobal.com/the-model-proposes-the-rules-engine-decides</link>
<guid isPermaLink="true">https://www.hermsglobal.com/the-model-proposes-the-rules-engine-decides</guid>
<pubDate>Mon, 16 Nov 2026 14:09:23 +0000</pubDate>
<category>GOVERNANCE</category>
<description>A governing principle for responsible AI in regulated healthcare: the model proposes, the rules engine decides and the audit trail records both.</description>
</item>
<item>
<title>Every Decision Sealed: Why Audit Trails Define Trust</title>
<link>https://www.hermsglobal.com/every-decision-sealed-why-audit-trails-define-trust</link>
<guid isPermaLink="true">https://www.hermsglobal.com/every-decision-sealed-why-audit-trails-define-trust</guid>
<pubDate>Mon, 16 Nov 2026 14:08:23 +0000</pubDate>
<category>GOVERNANCE</category>
<description>Traceability is becoming the baseline expectation in regulated healthcare.</description>
</item>
<item>
<title>One Standard for Government and Industry</title>
<link>https://www.hermsglobal.com/one-standard-for-government-and-industry</link>
<guid isPermaLink="true">https://www.hermsglobal.com/one-standard-for-government-and-industry</guid>
<pubDate>Mon, 16 Nov 2026 14:07:23 +0000</pubDate>
<category>APPLICATIONS</category>
<description>When regulators and manufacturers work from the same intelligence, friction falls on both sides.</description>
</item>
<item>
<title>Data Residency Is the Client&apos;s Choice</title>
<link>https://www.hermsglobal.com/data-residency-is-the-client-s-choice</link>
<guid isPermaLink="true">https://www.hermsglobal.com/data-residency-is-the-client-s-choice</guid>
<pubDate>Mon, 16 Nov 2026 14:06:23 +0000</pubDate>
<category>GOVERNANCE</category>
<description>Sovereignty and flexibility should not be a trade-off. HERMS lets each client choose where its data resides for regulated healthcare work.</description>
</item>
<item>
<title>Complementing Global Platforms with Local Judgment</title>
<link>https://www.hermsglobal.com/complementing-global-platforms-with-local-judgment</link>
<guid isPermaLink="true">https://www.hermsglobal.com/complementing-global-platforms-with-local-judgment</guid>
<pubDate>Mon, 16 Nov 2026 14:05:23 +0000</pubDate>
<category>PLATFORM</category>
<description>Global systems and local intelligence solve different parts of the same problem.</description>
</item>
<item>
<title>Seven Functions, One Connected View</title>
<link>https://www.hermsglobal.com/seven-functions-one-connected-view</link>
<guid isPermaLink="true">https://www.hermsglobal.com/seven-functions-one-connected-view</guid>
<pubDate>Mon, 16 Nov 2026 14:04:23 +0000</pubDate>
<category>APPLICATIONS</category>
<description>How 25 HERMS applications map to the full life sciences value chain, giving seven functions one connected view across the GCC.</description>
</item>
<item>
<title>Faster Patient Access, Every Decision Proven</title>
<link>https://www.hermsglobal.com/faster-patient-access-every-decision-proven</link>
<guid isPermaLink="true">https://www.hermsglobal.com/faster-patient-access-every-decision-proven</guid>
<pubDate>Mon, 16 Nov 2026 14:03:23 +0000</pubDate>
<category>PLATFORM</category>
<description>The outcome that matters to governments, clients, and investors alike.</description>
</item>
<item>
<title>When Access Is Delayed, Patients Pay the Price</title>
<link>https://www.hermsglobal.com/delayed-access-to-therapy-patient-risk</link>
<guid isPermaLink="true">https://www.hermsglobal.com/delayed-access-to-therapy-patient-risk</guid>
<pubDate>Mon, 16 Nov 2026 14:02:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Every month a therapy waits for registration, pricing or tender listing carries a clinical cost. HERMS explains the patient risks and how to shorten the path.</description>
</item>
<item>
<title>The Emirates Drug Establishment: What Changes for Pharmaceutical Companies in the UAE</title>
<link>https://www.hermsglobal.com/emirates-drug-establishment-uae-guide</link>
<guid isPermaLink="true">https://www.hermsglobal.com/emirates-drug-establishment-uae-guide</guid>
<pubDate>Mon, 16 Nov 2026 14:01:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>The Emirates Drug Establishment (EDE) is now the UAE federal authority for medical and pharmaceutical products. What manufacturers and importers should know.</description>
</item>
<item>
<title>Reliance Pathways in Saudi Arabia: Using FDA and EMA Approvals to Accelerate Registration</title>
<link>https://www.hermsglobal.com/sfda-verification-abridged-pathways</link>
<guid isPermaLink="true">https://www.hermsglobal.com/sfda-verification-abridged-pathways</guid>
<pubDate>Mon, 16 Nov 2026 14:00:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>SFDA&apos;s Verification and Abridged pathways can shorten registration for products approved by reference agencies. Learn when they apply and the pitfalls to avoid.</description>
</item>
<item>
<title>Winning Government Tenders in the GCC: From Registration to Award</title>
<link>https://www.hermsglobal.com/gcc-government-tenders-pharma-medical-devices</link>
<guid isPermaLink="true">https://www.hermsglobal.com/gcc-government-tenders-pharma-medical-devices</guid>
<pubDate>Mon, 16 Nov 2026 13:59:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Registration alone does not secure sales in the GCC. HERMS explains how unified procurement through NUPCO and the Gulf Health Council shapes tender strategy.</description>
</item>
<item>
<title>Pharmacovigilance in the GCC: Obligations Every Marketing Authorisation Holder Must Meet</title>
<link>https://www.hermsglobal.com/pharmacovigilance-obligations-gcc-mah</link>
<guid isPermaLink="true">https://www.hermsglobal.com/pharmacovigilance-obligations-gcc-mah</guid>
<pubDate>Mon, 16 Nov 2026 13:58:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>A practical guide to pharmacovigilance responsibilities for MAHs in the GCC: local QPPV, PSMF, case processing, periodic reports and inspection readiness.</description>
</item>
<item>
<title>Arabic Labelling and Artwork: The Most Avoidable Cause of Launch Delay</title>
<link>https://www.hermsglobal.com/arabic-labelling-artwork-compliance-gcc</link>
<guid isPermaLink="true">https://www.hermsglobal.com/arabic-labelling-artwork-compliance-gcc</guid>
<pubDate>Mon, 16 Nov 2026 13:57:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Late or non-compliant Arabic labelling delays GCC launches more often than many companies expect. HERMS outlines how to get artwork right first time.</description>
</item>
<item>
<title>Pricing and Market Access in the GCC: Building a Strategy Before You Submit</title>
<link>https://www.hermsglobal.com/gcc-pricing-market-access-strategy</link>
<guid isPermaLink="true">https://www.hermsglobal.com/gcc-pricing-market-access-strategy</guid>
<pubDate>Mon, 16 Nov 2026 13:56:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Price decisions in one GCC market affect the others. HERMS explains why pricing, reimbursement and value evidence must be planned before registration.</description>
</item>
<item>
<title>Promotional Compliance in the GCC: Marketing Healthcare Products Responsibly</title>
<link>https://www.hermsglobal.com/pharmaceutical-promotional-compliance-gcc</link>
<guid isPermaLink="true">https://www.hermsglobal.com/pharmaceutical-promotional-compliance-gcc</guid>
<pubDate>Mon, 16 Nov 2026 13:55:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Healthcare advertising in the GCC is regulated. HERMS explains the principles of compliant promotion for medicines, devices, cosmetics and supplements.</description>
</item>
<item>
<title>AI in Regulatory Affairs: Faster Intelligence, Human Accountability</title>
<link>https://www.hermsglobal.com/ai-regulatory-affairs-human-accountability</link>
<guid isPermaLink="true">https://www.hermsglobal.com/ai-regulatory-affairs-human-accountability</guid>
<pubDate>Mon, 16 Nov 2026 13:54:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>AI can speed up regulatory intelligence, dossier checks and safety review. HERMS explains how to use it responsibly with humans accountable for decisions.</description>
</item>
<item>
<title>Bringing Cell and Gene Therapies to the GCC: Readiness Beyond Registration</title>
<link>https://www.hermsglobal.com/cell-gene-therapy-gcc-readiness</link>
<guid isPermaLink="true">https://www.hermsglobal.com/cell-gene-therapy-gcc-readiness</guid>
<pubDate>Mon, 16 Nov 2026 13:53:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Cell and gene therapies demand more than a dossier. HERMS explains the regulatory, clinical, logistics and access readiness needed for GCC patients.</description>
</item>
<item>
<title>Pharmaceutical Product Registration in the UAE: How EDE Marketing Authorisation Works</title>
<link>https://www.hermsglobal.com/pharmaceutical-product-registration-uae</link>
<guid isPermaLink="true">https://www.hermsglobal.com/pharmaceutical-product-registration-uae</guid>
<pubDate>Mon, 16 Nov 2026 13:52:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Drug registration in the UAE: a regulatory roadmap for manufacturers under the Emirates Drug Establishment (EDE) — who registers, validity and what to do now.</description>
</item>
<item>
<title>Medical Device Labelling in the UAE and KSA: What Manufacturers Should Prepare</title>
<link>https://www.hermsglobal.com/medical-device-labelling-uae-ksa</link>
<guid isPermaLink="true">https://www.hermsglobal.com/medical-device-labelling-uae-ksa</guid>
<pubDate>Mon, 16 Nov 2026 13:51:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Explore medical device labelling in the UAE and Saudi Arabia, covering label content, language requirements and regulatory compliance considerations.</description>
</item>
<item>
<title>Medical Device Registration in the GCC: Planning a Country-Specific Market Entry Strategy</title>
<link>https://www.hermsglobal.com/medical-device-registration-gcc</link>
<guid isPermaLink="true">https://www.hermsglobal.com/medical-device-registration-gcc</guid>
<pubDate>Mon, 16 Nov 2026 13:50:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Explore medical device registration in the GCC, including country-specific requirements, documentation, local representation and market entry planning.</description>
</item>
<item>
<title>Life Sciences Software Solutions for the GCC: Regulatory, Safety, Tenders, Clinical and Market Access</title>
<link>https://www.hermsglobal.com/life-sciences-software-solutions-gcc</link>
<guid isPermaLink="true">https://www.hermsglobal.com/life-sciences-software-solutions-gcc</guid>
<pubDate>Mon, 16 Nov 2026 13:49:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>HERMS life sciences software for the UAE and GCC: regulatory intelligence, pharmacovigilance, tenders, promotional compliance, clinical and market access.</description>
</item>
<item>
<title>GCC Central Registration: How the Gulf Health Council Centralised Procedure Works</title>
<link>https://www.hermsglobal.com/gcc-central-registration-gulf-health-council</link>
<guid isPermaLink="true">https://www.hermsglobal.com/gcc-central-registration-gulf-health-council</guid>
<pubDate>Mon, 16 Nov 2026 13:48:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>How GCC-DR central registration works under the Gulf Health Council: site and product approval, national finalisation, pricing and five-year renewal.</description>
</item>
<item>
<title>Drug Registration Timelines: SFDA, MOHAP, EDE, EDA, EMA and FDA</title>
<link>https://www.hermsglobal.com/drug-registration-timelines-sfda-mohap-ede-eda-ema-fda</link>
<guid isPermaLink="true">https://www.hermsglobal.com/drug-registration-timelines-sfda-mohap-ede-eda-ema-fda</guid>
<pubDate>Mon, 16 Nov 2026 13:47:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Official registration review times for SFDA, MOHAP, Emirates Drug Establishment, Egypt EDA, EMA and FDA, each linked to the regulator source.</description>
</item>
<item>
<title>Drug Registration Timelines by Country: Australia, UK, Canada, Spain, Bahrain and More</title>
<link>https://www.hermsglobal.com/drug-registration-timelines-by-country-official-sources</link>
<guid isPermaLink="true">https://www.hermsglobal.com/drug-registration-timelines-by-country-official-sources</guid>
<pubDate>Mon, 16 Nov 2026 13:46:23 +0000</pubDate>
<category>INSIGHTS</category>
<description>Regulator-stated drug registration timelines for Australia, UK, Canada, Spain, Sweden, South Korea, Bahrain, Oman, Ghana and more, each with its official source.</description>
</item>
<item>
<title>The Cost of Delay</title>
<link>https://www.hermsglobal.com/white-paper-the-cost-of-delay</link>
<guid isPermaLink="true">https://www.hermsglobal.com/white-paper-the-cost-of-delay</guid>
<pubDate>Mon, 16 Nov 2026 08:40:00 +0000</pubDate>
<category>White paper</category>
<description>HERMS WHITE PAPER | WP1 | NOVEMBER 2026 The Cost of Delay Quantifying Patient and Commercial Impact of Late Therapy Access in the GCC Innovative</description>
</item>
<item>
<title>GCC Market Access Playbook</title>
<link>https://www.hermsglobal.com/white-paper-gcc-market-access-playbook</link>
<guid isPermaLink="true">https://www.hermsglobal.com/white-paper-gcc-market-access-playbook</guid>
<pubDate>Mon, 16 Nov 2026 08:40:00 +0000</pubDate>
<category>White paper</category>
<description>HERMS WHITE PAPER | WP2 | NOVEMBER 2026 GCC Market Access Playbook Registration, Pricing and Tender Sequencing In the GCC, a registration certificate</description>
</item>
<item>
<title>Regulatory Reliance in the GCC</title>
<link>https://www.hermsglobal.com/white-paper-regulatory-reliance-in-the-gcc</link>
<guid isPermaLink="true">https://www.hermsglobal.com/white-paper-regulatory-reliance-in-the-gcc</guid>
<pubDate>Mon, 16 Nov 2026 08:40:00 +0000</pubDate>
<category>White paper</category>
<description>HERMS WHITE PAPER | WP3 | NOVEMBER 2026 Regulatory Reliance in the GCC Using FDA/EMA Approvals to Accelerate Registration Every GCC state now offers</description>
</item>
<item>
<title>Cell and Gene Therapy Readiness in the Gulf</title>
<link>https://www.hermsglobal.com/white-paper-cell-and-gene-therapy-readiness-in-the-gulf</link>
<guid isPermaLink="true">https://www.hermsglobal.com/white-paper-cell-and-gene-therapy-readiness-in-the-gulf</guid>
<pubDate>Mon, 16 Nov 2026 08:40:00 +0000</pubDate>
<category>White paper</category>
<description>HERMS WHITE PAPER | WP4 | NOVEMBER 2026 Cell and Gene Therapy Readiness in the Gulf: From Approval to Patient Infusion A practical framework for</description>
</item>
<item>
<title>Governed AI in Regulatory Affairs</title>
<link>https://www.hermsglobal.com/white-paper-governed-ai-in-regulatory-affairs</link>
<guid isPermaLink="true">https://www.hermsglobal.com/white-paper-governed-ai-in-regulatory-affairs</guid>
<pubDate>Mon, 16 Nov 2026 08:40:00 +0000</pubDate>
<category>White paper</category>
<description>HERMS WHITE PAPER | WP5 | NOVEMBER 2026 Governed AI in Regulatory Affairs A Framework for Human-Accountable Intelligence Regulators in the United</description>
</item>
<item>
<title>GCC Tender Readiness</title>
<link>https://www.hermsglobal.com/white-paper-gcc-tender-readiness</link>
<guid isPermaLink="true">https://www.hermsglobal.com/white-paper-gcc-tender-readiness</guid>
<pubDate>Mon, 16 Nov 2026 08:40:00 +0000</pubDate>
<category>White paper</category>
<description>HERMS WHITE PAPER | WP6 | NOVEMBER 2026 GCC Tender Readiness Winning Public Procurement for Medicines in the Gulf In the Gulf, registration makes a</description>
</item>
<item>
<title>Agentic AI in Life Sciences: Which Decisions Can Be Automated—and Which Require Human Approval?</title>
<link>https://www.hermsglobal.com/agentic-ai-life-sciences-human-oversight</link>
<guid isPermaLink="true">https://www.hermsglobal.com/agentic-ai-life-sciences-human-oversight</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Which life sciences decisions can AI agents automate? Explore human approval boundaries, GxP validation, safety oversight and practical governance for deployment.</description>
</item>
<item>
<title>Agentic AI vs. Generative AI in Pharmaceuticals: Key Differences and Applications</title>
<link>https://www.hermsglobal.com/agentic-vs-generative-ai-pharmaceuticals</link>
<guid isPermaLink="true">https://www.hermsglobal.com/agentic-vs-generative-ai-pharmaceuticals</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Compare agentic and generative AI in pharmaceuticals: architectures, use cases, GxP controls, security risks and practical measures of business value.</description>
</item>
<item>
<title>AI Governance in Life Sciences: A Practical Framework for Pharmaceutical Companies</title>
<link>https://www.hermsglobal.com/ai-governance-life-sciences-pharmaceutical-framework</link>
<guid isPermaLink="true">https://www.hermsglobal.com/ai-governance-life-sciences-pharmaceutical-framework</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Build practical AI governance in life sciences with risk tiers, decision rights, GxP controls, vendor oversight and monitoring for pharmaceutical teams.</description>
</item>
<item>
<title>Human-in-the-Loop AI: Designing Approval Controls for Regulated Pharmaceutical Decisions</title>
<link>https://www.hermsglobal.com/human-in-the-loop-ai-pharmaceutical-approval-controls</link>
<guid isPermaLink="true">https://www.hermsglobal.com/human-in-the-loop-ai-pharmaceutical-approval-controls</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Design human approval controls for pharmaceutical AI: risk-based gates, decision rights, electronic records, escalation, validation and oversight KPIs.</description>
</item>
<item>
<title>Real-World Evidence: How to Build Studies That Support Regulatory and Market Access Decisions</title>
<link>https://www.hermsglobal.com/real-world-evidence-regulatory-market-access-studies</link>
<guid isPermaLink="true">https://www.hermsglobal.com/real-world-evidence-regulatory-market-access-studies</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Build real-world evidence studies for regulatory and market access decisions with fit-for-purpose data, sound design, confounding control and traceable analysis.</description>
</item>
<item>
<title>AI-Powered Medical Devices: A Lifecycle Guide to Validation and Change Control</title>
<link>https://www.hermsglobal.com/ai-medical-devices-validation-change-control</link>
<guid isPermaLink="true">https://www.hermsglobal.com/ai-medical-devices-validation-change-control</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Validate AI-powered medical devices across the lifecycle: intended use, clinical evidence, PCCPs, model change control and post-market monitoring explained.</description>
</item>
<item>
<title>Global Pharmaceutical Market Access: Connecting Clinical Value, HTA and Pricing Evidence</title>
<link>https://www.hermsglobal.com/global-pharmaceutical-market-access-hta-pricing-evidence</link>
<guid isPermaLink="true">https://www.hermsglobal.com/global-pharmaceutical-market-access-hta-pricing-evidence</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Connect clinical value, HTA and pricing evidence in global pharma market access, with practical guidance on uncertainty, budget impact and local requirements.</description>
</item>
<item>
<title>Preparing Healthcare Data for AI: Quality, Privacy, Interoperability and Provenance</title>
<link>https://www.hermsglobal.com/preparing-healthcare-data-for-ai</link>
<guid isPermaLink="true">https://www.hermsglobal.com/preparing-healthcare-data-for-ai</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Prepare healthcare data for AI with a practical guide to data quality, privacy, interoperability and provenance, plus readiness checks and common failure modes.</description>
</item>
<item>
<title>AI in Pharmaceutical Manufacturing: Quality Controls from Development to Commercial Supply</title>
<link>https://www.hermsglobal.com/ai-pharmaceutical-manufacturing-quality-controls</link>
<guid isPermaLink="true">https://www.hermsglobal.com/ai-pharmaceutical-manufacturing-quality-controls</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Explore AI in pharmaceutical manufacturing with practical controls for process monitoring, deviations, validation, human oversight and commercial supply.</description>
</item>
<item>
<title>Cosmetics Claims and Safety Evidence: Building a Defensible Global Product Dossier</title>
<link>https://www.hermsglobal.com/cosmetics-claims-safety-global-regulatory-dossier</link>
<guid isPermaLink="true">https://www.hermsglobal.com/cosmetics-claims-safety-global-regulatory-dossier</guid>
<pubDate>Mon, 16 Nov 2026 08:00:00 +0000</pubDate>
<category>LIFE SCIENCES AI</category>
<description>Build a defensible cosmetics dossier with practical guidance on claims substantiation, ingredient evidence, safety assessment and global regulatory differences.</description>
</item>
<item>
<title>Healthcare and Life Sciences Execution Intelligence for the UAE</title>
<link>https://www.hermsglobal.com/uae-healthcare-life-sciences-execution-intelligence</link>
<guid isPermaLink="true">https://www.hermsglobal.com/uae-healthcare-life-sciences-execution-intelligence</guid>
<pubDate>Fri, 13 Nov 2026 08:00:00 +0000</pubDate>
<category>White paper</category>
<description>Explore UAE healthcare and life sciences market entry across ADIO, Hub71, Mubadala, DoH, DHA, SEHA/PureHealth and DIFC. Download the HERMS white paper.</description>
</item>
<item>
<title>GCC Health-System Priorities for Resilient, Data-Driven Care</title>
<link>https://www.hermsglobal.com/priorities-gcc-health-systems</link>
<guid isPermaLink="true">https://www.hermsglobal.com/priorities-gcc-health-systems</guid>
<pubDate>Thu, 12 Nov 2026 08:00:00 +0000</pubDate>
<category>INSIGHTS</category>
<description>Evidence-backed priorities for GCC health systems: resilient supply chains, digital health, primary care, preparedness, procurement and responsible AI.</description>
</item>
<item>
<title>Medical Device Registration in UAE</title>
<link>https://www.hermsglobal.com/medical-device-registration-uae</link>
<guid isPermaLink="true">https://www.hermsglobal.com/medical-device-registration-uae</guid>
<pubDate>Mon, 12 May 2025 06:04:09 +0000</pubDate>
<description>Looking for medical device registration in UAE? Herms Global guides you through MOHAP’s regulatory process, requirements, timelines, and compliance tips.</description>
</item>
<item>
<title>Hassle-Free Over-the-Counter Registration for Quick Market Access</title>
<link>https://www.hermsglobal.com/over-the-counter-registration</link>
<guid isPermaLink="true">https://www.hermsglobal.com/over-the-counter-registration</guid>
<pubDate>Mon, 05 May 2025 15:18:39 +0000</pubDate>
<description>Learn the regulatory process for over-the-counter (OTC) product registration in the UAE to ensure compliance with MOHAP and swift market authorization.</description>
</item>
<item>
<title>Herbal medicine registration in UAE</title>
<link>https://www.hermsglobal.com/herbal-medicine-registration-uae</link>
<guid isPermaLink="true">https://www.hermsglobal.com/herbal-medicine-registration-uae</guid>
<pubDate>Tue, 15 Apr 2025 13:40:40 +0000</pubDate>
<description>Discover the full process and regulatory guidelines for herbal medicine registration in the UAE, ensuring compliance with MOHAP and safe market access.</description>
</item>
<item>
<title>Cosmetic registration in Dubai Municipality</title>
<link>https://www.hermsglobal.com/cosmetics-registration-dubai-municipality</link>
<guid isPermaLink="true">https://www.hermsglobal.com/cosmetics-registration-dubai-municipality</guid>
<pubDate>Tue, 15 Apr 2025 13:38:50 +0000</pubDate>
<description>Learn the process &amp; requirements for registering cosmetics with Dubai Municipality, ensuring product compliance &amp; successful market access in the UAE.</description>
</item>
<item>
<title>Oman Medical Device Regulations</title>
<link>https://www.hermsglobal.com/oman-medical-device-regulations</link>
<guid isPermaLink="true">https://www.hermsglobal.com/oman-medical-device-regulations</guid>
<pubDate>Fri, 24 Feb 2023 22:50:22 +0000</pubDate>
<category>White paper</category>
<description>Understand Oman’s regulatory framework for medical devices, including MDR requirements and the approval process to ensure compliant market entry.</description>
</item>
<item>
<title>Lebanon Medical Device Regulations</title>
<link>https://www.hermsglobal.com/lebanon-medical-device-regulations</link>
<guid isPermaLink="true">https://www.hermsglobal.com/lebanon-medical-device-regulations</guid>
<pubDate>Fri, 24 Feb 2023 22:49:00 +0000</pubDate>
<category>White paper</category>
<description>Learn about Lebanon’s medical device registration process, including Ministry of Public Health requirements and compliance for successful market access.</description>
</item>
<item>
<title>Jordan Medical Device Regulations</title>
<link>https://www.hermsglobal.com/jordan-medical-device-regulations</link>
<guid isPermaLink="true">https://www.hermsglobal.com/jordan-medical-device-regulations</guid>
<pubDate>Fri, 24 Feb 2023 22:47:36 +0000</pubDate>
<category>White paper</category>
<description>Get Review the regulatory process for medical device registration in Jordan, including JFDA requirements and key steps for smooth market approval</description>
</item>
<item>
<title>Procedure for registration of pharmaceuticals in Egypt</title>
<link>https://www.hermsglobal.com/procedure-registration-pharmaceuticals-egypt</link>
<guid isPermaLink="true">https://www.hermsglobal.com/procedure-registration-pharmaceuticals-egypt</guid>
<pubDate>Fri, 24 Feb 2023 22:46:33 +0000</pubDate>
<category>White paper</category>
<description>Explore the procedures for pharmaceutical product registration in UAE , ensuring regulatory compliance and efficient access to the UAE market for growth</description>
</item>
<item>
<title>Bahrain Medical Device Regulations</title>
<link>https://www.hermsglobal.com/bahrain-medical-device-regulations</link>
<guid isPermaLink="true">https://www.hermsglobal.com/bahrain-medical-device-regulations</guid>
<pubDate>Fri, 24 Feb 2023 22:34:28 +0000</pubDate>
<category>White paper</category>
<description>Understand Bahrain’s medical device regulations &amp; NHRA needs to ensure compliant product registration &amp; streamlined market entry with HermsGlobal</description>
</item>
<item>
<title>An overview of pharma markets in Middle East</title>
<link>https://www.hermsglobal.com/overview-pharma-markets-middle-east</link>
<guid isPermaLink="true">https://www.hermsglobal.com/overview-pharma-markets-middle-east</guid>
<pubDate>Fri, 24 Feb 2023 22:25:15 +0000</pubDate>
<description>Gain an overview of pharmaceutical markets in the Middle East, covering market size, emerging trends, &amp; regulatory environments shaping industry growth</description>
</item>
<item>
<title>Challenges in eCTD Publishing &amp; Submission Management</title>
<link>https://www.hermsglobal.com/challenges-ectd-publishing-submission-management</link>
<guid isPermaLink="true">https://www.hermsglobal.com/challenges-ectd-publishing-submission-management</guid>
<pubDate>Fri, 24 Feb 2023 22:23:41 +0000</pubDate>
<description>Understand the challenges in eCTD publishing &amp; submission management, with focus on improving assent, efficiency, &amp; meeting regulatory requirements.</description>
</item>
<item>
<title>Challenges in GCC pharma and medical devices sector</title>
<link>https://www.hermsglobal.com/challenges-gcc-pharma-medical-devices-sector</link>
<guid isPermaLink="true">https://www.hermsglobal.com/challenges-gcc-pharma-medical-devices-sector</guid>
<pubDate>Fri, 24 Feb 2023 22:22:07 +0000</pubDate>
<description>Examine the regulatory and operational challenges faced by the pharmaceutical &amp; medical device sectors in the GCC, focusing on assent &amp; market access</description>
</item>
<item>
<title>Challenges in ICSR processing</title>
<link>https://www.hermsglobal.com/challenges-icsr-processing</link>
<guid isPermaLink="true">https://www.hermsglobal.com/challenges-icsr-processing</guid>
<pubDate>Fri, 24 Feb 2023 22:19:46 +0000</pubDate>
<description>Explore the complexities of Individual Case Safety Report (ICSR) processing and discover solutions for pharmacovigilance &amp; regulatory compliance</description>
</item>
<item>
<title>Common Medical Device Regulatory Compliance Roadblocks</title>
<link>https://www.hermsglobal.com/common-medical-device-regulatory-compliance-roadblocks</link>
<guid isPermaLink="true">https://www.hermsglobal.com/common-medical-device-regulatory-compliance-roadblocks</guid>
<pubDate>Fri, 24 Feb 2023 22:17:26 +0000</pubDate>
<description>Identify common regulatory compliance challenges in the medical device sector and explore effective strategies to overcome these obstacles for market</description>
</item>
<item>
<title>Healthcare opportunities and challenges in Saudi Arabia</title>
<link>https://www.hermsglobal.com/healthcare-opportunities-challenges-saudi-arabia</link>
<guid isPermaLink="true">https://www.hermsglobal.com/healthcare-opportunities-challenges-saudi-arabia</guid>
<pubDate>Fri, 24 Feb 2023 22:14:16 +0000</pubDate>
<description>Analyze the evolving healthcare landscape in Saudi Arabia, highlighting key opportunities and challenges for stakeholders in the region’s healthcare sector.</description>
</item>
<item>
<title>Importance of medical devices in healthcare</title>
<link>https://www.hermsglobal.com/importance-medical-devices-registration-uae</link>
<guid isPermaLink="true">https://www.hermsglobal.com/importance-medical-devices-registration-uae</guid>
<pubDate>Fri, 24 Feb 2023 22:08:10 +0000</pubDate>
<description>Learn about the importance and process of medical device registration in the UAE, ensuring full compliance with local regulations for successful market</description>
</item>
<item>
<title>Market Access for Pharma and Medical Devices in MENA Region</title>
<link>https://www.hermsglobal.com/market-access-pharma-medical-devices-mena-region</link>
<guid isPermaLink="true">https://www.hermsglobal.com/market-access-pharma-medical-devices-mena-region</guid>
<pubDate>Fri, 24 Feb 2023 22:03:27 +0000</pubDate>
<description>Understand the pathways and challenges for market access of pharmaceutical and medical device products in the MENA region, focusing on regulations</description>
</item>
<item>
<title>Middle East Dermal Fillers Market Overview</title>
<link>https://www.hermsglobal.com/middle-east-dermal-fillers-market-overview</link>
<guid isPermaLink="true">https://www.hermsglobal.com/middle-east-dermal-fillers-market-overview</guid>
<pubDate>Fri, 24 Feb 2023 21:52:46 +0000</pubDate>
<description>Explore the expanding dermal fillers market in the Middle East, focusing on demand, regulatory factors, and market dynamics driving growth in the region.</description>
</item>
<item>
<title>Morocco Pharma Market</title>
<link>https://www.hermsglobal.com/morocco-pharma-market</link>
<guid isPermaLink="true">https://www.hermsglobal.com/morocco-pharma-market</guid>
<pubDate>Fri, 24 Feb 2023 21:47:50 +0000</pubDate>
<description>Gain insights into Morocco&apos;s pharmaceutical market, covering the regulatory landscape, market trends, and investment opportunities for industry growth.</description>
</item>
<item>
<title>NHRA Guidance on Medical Device Importation Process</title>
<link>https://www.hermsglobal.com/importation-process-nhra-guidance-medical-device</link>
<guid isPermaLink="true">https://www.hermsglobal.com/importation-process-nhra-guidance-medical-device</guid>
<pubDate>Fri, 24 Feb 2023 21:43:38 +0000</pubDate>
<description>Get Navigate NHRA’s medical device importation process in Bahrain, with clear insights into regulatory steps required for successful market entry.</description>
</item>
<item>
<title>NHRA Guidance on Medical Device Registration</title>
<link>https://www.hermsglobal.com/nhra-guidance-on-medical-device-registration</link>
<guid isPermaLink="true">https://www.hermsglobal.com/nhra-guidance-on-medical-device-registration</guid>
<pubDate>Fri, 24 Feb 2023 21:36:07 +0000</pubDate>
<description>Access detailed guidance on registering medical devices with the NHRA, ensuring full compliance with current medical device regulatory requirements.</description>
</item>
<item>
<title>Outsourcing regulatory compliance solutions</title>
<link>https://www.hermsglobal.com/outsourcing-regulatory-compliance-solutions</link>
<guid isPermaLink="true">https://www.hermsglobal.com/outsourcing-regulatory-compliance-solutions</guid>
<pubDate>Fri, 24 Feb 2023 21:28:05 +0000</pubDate>
<description>Explore outsourcing strategies for regulatory compliance to boost efficiency while meeting both regional and international regulatory requirements.</description>
</item>
<item>
<title>Role of Regulatory Affairs in Pharma Industry</title>
<link>https://www.hermsglobal.com/role-regulatory-affairs-pharma-industry</link>
<guid isPermaLink="true">https://www.hermsglobal.com/role-regulatory-affairs-pharma-industry</guid>
<pubDate>Fri, 24 Feb 2023 21:22:23 +0000</pubDate>
<description>Understand the critical role of regulatory affairs in ensuring compliance, market access, and lifecycle management in the pharmaceutical sector.</description>
</item>
<item>
<title>Steps to streamline regulatory processes in the Middle East</title>
<link>https://www.hermsglobal.com/steps-streamline-regulatory-processes-middle-east</link>
<guid isPermaLink="true">https://www.hermsglobal.com/steps-streamline-regulatory-processes-middle-east</guid>
<pubDate>Fri, 24 Feb 2023 21:19:17 +0000</pubDate>
<description>Explore effective strategies to accelerate drug approvals in the Middle East, including EU/FDA reliance models and streamlined registration systems.</description>
</item>
<item>
<title>Trends and Challenges Facing MENA Pharmaceutical Sector</title>
<link>https://www.hermsglobal.com/trends-challenges-facing-mena-pharmaceutical-sector</link>
<guid isPermaLink="true">https://www.hermsglobal.com/trends-challenges-facing-mena-pharmaceutical-sector</guid>
<pubDate>Fri, 24 Feb 2023 21:16:38 +0000</pubDate>
<description>Analyze major trends and regulatory challenges in the MENA pharmaceutical market, with a focus on compliance, pricing, and market access barriers.</description>
</item>
<item>
<title>Algeria health sector market</title>
<link>https://www.hermsglobal.com/algeria-health-sector-market</link>
<guid isPermaLink="true">https://www.hermsglobal.com/algeria-health-sector-market</guid>
<pubDate>Wed, 22 Feb 2023 23:44:15 +0000</pubDate>
<description>Explore Algeria&apos;s healthcare market, highlighting public-private dynamics, pharmaceutical growth, and evolving regulatory frameworks for market entry.</description>
</item>
</channel>
</rss>
